10-87960876-CTTTTTTTTT-CTTTTTTTTTTTT
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 4P and 16B. PVS1_StrongBP6_Very_StrongBS1BS2
The NM_000314.8(PTEN):c.802-5_802-3dupTTT variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,424,064 control chromosomes in the GnomAD database, including 9 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0075 ( 8 hom., cov: 26)
Exomes 𝑓: 0.00069 ( 1 hom. )
Consequence
PTEN
NM_000314.8 splice_acceptor, intron
NM_000314.8 splice_acceptor, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.37
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.18481848 fraction of the gene. Cryptic splice site detected, with MaxEntScore 13, offset of 0 (no position change), new splice context is: ttttttttttttttttttAGgac. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
BP6
Variant 10-87960876-C-CTTT is Benign according to our data. Variant chr10-87960876-C-CTTT is described in ClinVar as [Likely_benign]. Clinvar id is 802611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00751 (940/125116) while in subpopulation AFR AF= 0.0279 (886/31784). AF 95% confidence interval is 0.0264. There are 8 homozygotes in gnomad4. There are 426 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 SM gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.802-5_802-3dupTTT | splice_acceptor_variant, intron_variant | ENST00000371953.8 | NP_000305.3 | |||
PTEN | NM_001304717.5 | c.1321-5_1321-3dupTTT | splice_acceptor_variant, intron_variant | NP_001291646.4 | ||||
PTEN | NM_001304718.2 | c.211-5_211-3dupTTT | splice_acceptor_variant, intron_variant | NP_001291647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTEN | ENST00000371953.8 | c.802-5_802-3dupTTT | splice_acceptor_variant, intron_variant | 1 | NM_000314.8 | ENSP00000361021.3 |
Frequencies
GnomAD3 genomes AF: 0.00749 AC: 937AN: 125120Hom.: 8 Cov.: 26
GnomAD3 genomes
AF:
AC:
937
AN:
125120
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000693 AC: 900AN: 1298948Hom.: 1 Cov.: 0 AF XY: 0.000680 AC XY: 440AN XY: 646756
GnomAD4 exome
AF:
AC:
900
AN:
1298948
Hom.:
Cov.:
0
AF XY:
AC XY:
440
AN XY:
646756
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00751 AC: 940AN: 125116Hom.: 8 Cov.: 26 AF XY: 0.00705 AC XY: 426AN XY: 60426
GnomAD4 genome
AF:
AC:
940
AN:
125116
Hom.:
Cov.:
26
AF XY:
AC XY:
426
AN XY:
60426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Dec 16, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Breast and/or ovarian cancer Benign:1
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jun 01, 2023 | - - |
PTEN hamartoma tumor syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 26, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at